Sucharita Adluri

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Philip O. Livingston, Gabriel Wong, Sucharita Adluri et al. · Journal of Clinical Oncology · 1994 · 518 citations

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

Shengle Zhang, Carlos Cordon‐Cardo, Helen S. Zhang et al. · International Journal of Cancer · 1997 · 277 citations

Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

Susan F. Slovin, Govindaswami Ragupathi, Sucharita Adluri et al. · Proceedings of the National Academy of Sciences · 1999 · 253 citations · Full text

Immunocytochemical Technique, Immunology, Immunoediting +19

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

Philip O. Livingston, Sucharita Adluri, Friedhelm Helling et al. · Vaccine · 1994 · 214 citations

Vaccination, Melanoma, Immunology +11

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.

Friedhelm Helling, Shengle Zhang, A Shang et al. · PubMed · 1995 · 207 citations

Immunology, Immunologic Mechanism, Immunotherapeutics +19